SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Residual risk and waste in donated blood with pooled nucleic acid testing
16 references·0 citing·37 second hop
Residual risk and waste in donated blood with pooled nucleic acid testing (2016)Residual risk and waste in donated blood …Comparative analysis of triplex nucleic acid test assays in United States blood donors (2013)Comparative analysis of tripl…Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms (2010)Refinement of a viral transmi…Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa (2009)Impact of individual‐donation…BLOOD DONORS AND BLOOD COLLECTION: Web interface–supported transmission risk assessment and cost‐effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands (2009)BLOOD DONORS AND BLOOD COLLEC…A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)A new strategy for estimating…Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Cost‐effectiveness of nucleic…The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)The cost‐effectiveness of NAT…Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window‐phase donations not detected by NAT (2002)Mathematic modeling of the ri…HIV, HBV and HCV: new developments related to transfusion safety. (2000)HIV, HBV and HCV: new develop…HIV, HBV and HCV: New Developments Related to Transfusion Safety (2000)HIV, HBV and HCV: New Develop…The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)The incidence/window period m…Safety of the Blood Supply in the United States: Opportunities and Controversies (1997)Safety of the Blood Supply in…Pooled Testing for HIV Screening: Capturing the Dilution Effect (1996)Pooled Testing for HIV Screen…Efficient pooling designs for library screening (1995)Efficient pooling designs for…The use of a square array scheme in blood testing (1994)The use of a square array sch…Inspection Errors for Attributes in Quality Control (1991)Inspection Errors for Attribu…Recommendations for Reporting Cost-effectiveness Analyses (1996)The Risk of Transfusion-Transmitted Viral Infections (1996)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Probability of Viremia with HBV, HCV, HIV, and HTLV among Tissue Donors in the United States (2004)Estimating the cost of blood: past, present, and future directions (2007)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody (1988)Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative (1989)Evaluation of Screened Blood Donations for Human Immunodeficiency Virus Type 1 Infection by Culture and DNA Amplification of Pooled Cells (1991)International application of the Incidence Rate/Window Period model (2002)Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services (2007)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood (2011)Problems and Approaches for Blood Transfusion in the Developing Countries (2016)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes (2018)Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 2016 (2020)HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men (2021)Methods for the economic evaluation of health care programmes (1987)Perception of Risk (1987)Cost-Effectiveness in Health and Medicine (1996)Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus (2005)Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low‐resource settings (2017)A Comparative Survey of Non-Adaptive Pooling Designs (1996)Group testing problems with sequences in experimental molecular biology (2002)A new pooling strategy for high-throughput screening: the Shifted Transversal Design (2006)Karl landsteiner and his major contributions to haematology (2003)Lessons from Cost-Effectiveness Research for United States Public Health Policy (2007)Applications of bulk queues to group testing models with incomplete identification (2006)Dynamic Control of a Multiclass Queue with Thin Arrival Streams (2006)Dynamic Control of a Make-to-Order, Parallel-Server System with Cancellations (2008)Transfusion-transmitted infections (2007)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Prevention of transfusion-transmitted infections (2019)Optimal control limits for CCC charts in the presence of inspection errors (2003)Assessing a Binary Measurement System (2008)Visualizing and Assessing Acceptance Sampling Plans: TheRPackageAcceptanceSampling (2008)
this work references cited by second hop

References

  • 2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
  • 2003The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations264 cited
  • 1997Safety of the Blood Supply in the United States: Opportunities and Controversies173 cited
  • 1997The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection168 cited
  • 2009Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa139 cited
  • 1995Efficient pooling designs for library screening137 cited
  • 2004Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States136 cited
  • 1991Inspection Errors for Attributes in Quality Control134 cited
  • 2010Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms131 cited
  • 1996Pooled Testing for HIV Screening: Capturing the Dilution Effect130 cited
  • 2002Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window‐phase donations not detected by NAT117 cited
  • 1994The use of a square array scheme in blood testing114 cited
  • 2013

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Comparative analysis of triplex nucleic acid test assays in United States blood donors
62 cited
  • 2000HIV, HBV and HCV: new developments related to transfusion safety.43 cited
  • 2000HIV, HBV and HCV: New Developments Related to Transfusion Safety33 cited
  • 2009BLOOD DONORS AND BLOOD COLLECTION: Web interface–supported transmission risk assessment and cost‐effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands31 cited
  • Cited by

    No citing works inside the corpus for this window.